Subtopic Deep Dive

Opportunistic Infections in Cystic Fibrosis
Research Guide

What is Opportunistic Infections in Cystic Fibrosis?

Opportunistic infections in cystic fibrosis involve lung colonization by multidrug-resistant bacteria such as Pseudomonas aeruginosa, Stenotrophomonas maltophilia, and Achromobacter xylosoxidans, leading to accelerated lung function decline.

These infections arise in CF patients due to impaired mucociliary clearance, enabling pathogens like S. maltophilia from sputum and environmental sources (Crossman et al., 2008, 541 citations). Longitudinal studies reveal shifting bacteriology with emerging resistance (Salsgiver et al., 2015, 232 citations). Bacterial diversity profiling using 16S rDNA methods identifies uncultured species in CF lungs (Rogers et al., 2003, 232 citations). Over 20 key papers document prevalence and resistance mechanisms.

Curated Papers

Key Challenges

Why It Matters

Opportunistic pathogens erode gains from CFTR modulators by causing persistent infections resistant to standard therapies, necessitating targeted eradication protocols. Pseudomonas aeruginosa employs MexXY efflux pumps for aminoglycoside resistance during chemotherapy (Morita et al., 2012, 191 citations), while Stenotrophomonas maltophilia acquires sul genes for trimethoprim/sulfamethoxazole resistance, complicating treatment in CF clinics (Toleman et al., 2007, 209 citations). Achromobacter xylosoxidans colonization correlates with worse lung function, as shown in prevalence studies (De Baets et al., 2006, 158 citations). These dynamics drive clinic transmission tracking and personalized antimicrobial strategies.

Key Research Challenges

Emerging Multidrug Resistance

Pathogens like Pseudomonas aeruginosa develop intrinsic and acquired resistance via efflux systems during therapy (Poole, 2011, 918 citations). Stenotrophomonas maltophilia shields itself with multiple drug resistance determinants in its genome (Crossman et al., 2008, 541 citations). This compromises anti-pseudomonal chemotherapy in CF lungs.

Detecting Bacterial Diversity

Standard cultures miss uncultured species in CF sputum, requiring 16S rDNA PCR profiling (Rogers et al., 2003, 232 citations). Longitudinal genotyping tracks clinic transmission of Achromobacter xylosoxidans (De Baets et al., 2006, 158 citations). Heterogeneity challenges accurate pathogen identification.

Shifting Pathogen Epidemiology

CF respiratory bacteriology evolves with rising non-traditional pathogens like S. maltophilia (Salsgiver et al., 2015, 232 citations). TMP/SMX resistance emerges globally via sul gene acquisition (Toleman et al., 2007, 209 citations). This alters eradication protocols amid modulator therapies.

Essential Papers

Pseudomonas Aeruginosa: Resistance to the Max

Keith Poole · 2011 · Frontiers in Microbiology · 918 citations

Pseudomonas aeruginosa is intrinsically resistant to a variety of antimicrobials and can develop resistance during anti-pseudomonal chemotherapy both of which compromise treatment of infections cau...

The complete genome, comparative and functional analysis of Stenotrophomonas maltophiliareveals an organism heavily shielded by drug resistance determinants

Lisa Crossman, Virginia C. Gould, J. Maxwell Dow et al. · 2008 · Genome biology · 541 citations

Abstract Background Stenotrophomonas maltophilia is a nosocomial opportunistic pathogen of the Xanthomonadaceae. The organism has been isolated from both clinical and soil environments in addition ...

Mechanisms of antimicrobial resistance in Gram-negative bacilli

Étienne Ruppé, Paul‐Louis Woerther, François Barbier · 2015 · Annals of Intensive Care · 472 citations

The burden of multidrug resistance in Gram-negative bacilli (GNB) now represents a daily issue for the management of antimicrobial therapy in intensive care unit (ICU) patients. In Enterobacteriace...

Stenotrophomonas maltophilia as an Emerging Ubiquitous Pathogen: Looking Beyond Contemporary Antibiotic Therapy

Anthony A. Adegoke, Thor Axel Stenström, Anthony I. Okoh · 2017 · Frontiers in Microbiology · 301 citations

<i>Stenotrophomonas maltophilia</i> is a commensal and an emerging pathogen earlier noted in broad-spectrum life threatening infections among the vulnerable, but more recently as a pathogen in immu...

Bacterial Diversity in Cases of Lung Infection in Cystic Fibrosis Patients: 16S Ribosomal DNA (rDNA) Length Heterogeneity PCR and 16S rDNA Terminal Restriction Fragment Length Polymorphism Profiling

Geraint B. Rogers, C. A. Hart, J. R. Mason et al. · 2003 · Journal of Clinical Microbiology · 232 citations

ABSTRACT The leading cause of morbidity and mortality in cystic fibrosis (CF) patients stems from repeated bacterial respiratory infections. Many bacterial species have been cultured from CF specim...

Changing Epidemiology of the Respiratory Bacteriology of Patients With Cystic Fibrosis

Elizabeth Salsgiver, Aliza K. Fink, Emily A. Knapp et al. · 2015 · CHEST Journal · 232 citations

Pulmonary infections in patients with cystic fibrosis

S. Rajan · 2002 · Seminars in Respiratory Infections · 224 citations

Reading Guide

Foundational Papers

Start with Poole (2011, 918 citations) for Pseudomonas resistance mechanisms; Crossman et al. (2008, 541 citations) for S. maltophilia genomics; Rogers et al. (2003, 232 citations) for CF bacterial diversity methods, as they establish core resistance and detection paradigms.

Recent Advances

Study Salsgiver et al. (2015, 232 citations) for epidemiology shifts; Adegoke et al. (2017, 301 citations) for S. maltophilia pathogenicity; Ruppé et al. (2015, 472 citations) for Gram-negative resistance mechanisms.

Core Methods

16S rDNA PCR profiling (Rogers et al., 2003); genome analysis for resistance determinants (Crossman et al., 2008); longitudinal bacteriology surveillance (Salsgiver et al., 2015); sul gene detection for TMP/SMX resistance (Toleman et al., 2007).

How PapersFlow Helps You Research Opportunistic Infections in Cystic Fibrosis

Discover & Search

PapersFlow's Research Agent uses searchPapers and exaSearch to query 'Achromobacter xylosoxidans cystic fibrosis lung colonization' yielding De Baets et al. (2006), then citationGraph reveals forward citations on transmission risks and findSimilarPapers uncovers Rogers et al. (2003) for 16S profiling methods.

Analyze & Verify

Analysis Agent applies readPaperContent to parse Crossman et al. (2008) genome details on S. maltophilia resistance determinants, verifyResponse with CoVe cross-checks claims against Poole (2011), and runPythonAnalysis with pandas/matplotlib visualizes resistance trends from Salsgiver et al. (2015) datasets if extracted. GRADE grading scores evidence strength for MexXY pump mechanisms (Morita et al., 2012).

Synthesize & Write

Synthesis Agent detects gaps in Achromobacter eradication protocols post-De Baets et al. (2006), flags contradictions between TMP/SMX resistance rates (Toleman et al., 2007) and clinical outcomes. Writing Agent uses latexEditText for protocol drafts, latexSyncCitations integrates Poole (2011), and latexCompile generates review PDFs; exportMermaid diagrams pathogen transmission networks.

Use Cases

"Analyze S. maltophilia resistance gene prevalence in CF sputum datasets."

Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas counts sul genes from Crossman et al. 2008 tables) → matplotlib plots frequency → GRADE verification → CSV export of stats.

"Draft LaTeX review on Pseudomonas resistance mechanisms in CF."

Synthesis Agent → gap detection in Poole (2011) → Writing Agent → latexEditText for intro → latexSyncCitations adds Morita et al. (2012) → latexCompile → PDF with resistance efflux diagram via latexGenerateFigure.

"Find code for 16S rDNA analysis in CF bacterial diversity papers."

Research Agent → searchPapers '16S rDNA cystic fibrosis' → paperExtractUrls from Rogers et al. (2003) → paperFindGithubRepo → githubRepoInspect → runPythonAnalysis on repo scripts for T-RFLP profiling.

Automated Workflows

Deep Research workflow conducts systematic review of 50+ CF infection papers via searchPapers → citationGraph on Poole (2011), generating structured reports on resistance evolution. DeepScan applies 7-step analysis with CoVe checkpoints to verify S. maltophilia genome claims (Crossman et al., 2008). Theorizer generates hypotheses on Achromobacter transmission from De Baets et al. (2006) and clinic genotyping data.

Try Doxa for Opportunistic Infections in Cystic Fibrosis Research

Frequently Asked Questions

What defines opportunistic infections in cystic fibrosis?

They are lung colonizations by resistant bacteria like Pseudomonas aeruginosa, Stenotrophomonas maltophilia, and Achromobacter xylosoxidans in CF patients with impaired clearance (Rogers et al., 2003).

What methods detect bacterial diversity in CF lungs?

16S rDNA length heterogeneity PCR and terminal restriction fragment length polymorphism profile uncultured species from sputum (Rogers et al., 2003, 232 citations).

What are key papers on CF pathogens?

Poole (2011, 918 citations) on Pseudomonas resistance; Crossman et al. (2008, 541 citations) on S. maltophilia genome; De Baets et al. (2006, 158 citations) on Achromobacter prevalence.

What open problems exist in this area?

Tracking clinic transmission via genotyping, overcoming TMP/SMX resistance in S. maltophilia (Toleman et al., 2007), and correlating emerging pathogens with lung decline post-modulators.